Anika Therapeutics, Inc. — Director's Dealing 2021

Apr 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2021-04-26

Reporting Person: Blanchard Cheryl R (Director, President, CEO, Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-26	Common Stock	M	24575	—	Acquired	34478	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-26	Restricted Stock Unit	$0.00	M	24575	Disposed		Common Stock (24575)	Direct

Footnotes

F1: Reflects the first vesting installment of RSUs granted on April 26, 2020. The 24,575 shares resulting from the RSU vest were retained in full as a result of Dr. Blanchard's election to pay cash to cover the applicable taxes resulting from the RSU vest.

F2: Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021.